The final, formatted version of the article will be published soon.
METHODS article
Front. Oncol.
Sec. Radiation Oncology
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1358487
This article is part of the Research Topic Radiation Therapy Using MRI-LINAC - the Right Way to Start: a Guide for Physicians and Physicists vol II View all 7 articles
Quality Assurance of an Established Online Adaptive Radiotherapy (ART) Program: Patch and Software Upgrade
Provisionally accepted
Nema Bassiri
1,2*
John Bayouth
3
Michael D. Chuong
1,2
Rupesh Kotecha
1,2
Yonatan Weiss
1,2
Minesh P. Mehta
1,2
Alonso N. Gutierrez
1,2
Kathryn E. Mittauer
1,2- 1 Miami Cancer Institute, Baptist Hospital of Miami, Miami, United States
- 2 Florida International University, Miami, Florida, United States
- 3 Oregon Health and Science University, Portland, Oregon, United States
densities demonstrated comparable agreement between TPS and TDS. ( 7) ART absolute and predicted measured doses was within 1% of calculated TDS.Discussion: An online ART QA program for post-software upgrade has been developed and implemented on an MR Linac system. Testing mechanics and their respective baselines may vary across institutions, but all necessary components for a post-software upgrade QA have been outlined and detailed. These outlined tests were demonstrated feasible for a low-field MR Linac system; however, the scope of this work may be applied and adapted more broadly to other online ART platforms.
Keywords: Quality Assurance, Software upgrade, adaptive radiotherapy, treatment planning system, End-to-end testing, MR Linear Accelerator
Received: 19 Dec 2023; Accepted: 07 May 2024.
Copyright: © 2024 Bassiri, Bayouth, Chuong, Kotecha, Weiss, Mehta, Gutierrez and Mittauer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Nema Bassiri, Miami Cancer Institute, Baptist Hospital of Miami, Miami, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.